Blood Test to Detect Prenatal Genetic Defects to Soon be a Reality23-Oct-2018
A recent article on BillionToOne:
A unique healthcare innovation by a young Indian scientist has the potential to radically change how prenatal genetic testing is done to identify fetal abnormalities.
FIT interviews Sukrit Silas, a PhD from Stanford and the Chief Science Officer at BillionToOne, a Y Combinator Company. They’ve developed a non-invasive prenatal test from maternal blood that allows doctors to detect genetic abnormalities in a fetus.
Currently, if the doctors suspect any abnormalities, expectant mothers go through an invasive and risky procedure called amniocentesis. The procedure involves a large hollow needle that is inserted into the uterus to pull out a small amount of amniotic fluid from a sac that surrounds the fetus. The fluid is then screened for chromosomal abnormalities and infections.